Ticker Symbol: CVAC
CureVac N.V.
$36.95 - 20-12-2024 4 p.m. ET
Exchange: NASDAQ
Country:
Germany
Currency:
USD
Asset
Type: Common Stock
CIK:0001809122
Company Profile
CureVac N.V. operates as a global clinical-stage biopharmaceutical company. The Company focuses on developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. CureVac serves customers worldwide.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: Friedrich-Miescher-Str. 15
Website: www.curevac.com
CEO: N/A
Tags:
- Health Technology
- Pharmaceuticals: Major
Pricing
Last Updated: October 3, 2023 03:00 PM EST
Previous Close: $6.30
Change:
-$0.11
(
-1.72%)
Days Range: $6.11 - $6.42
Beta: 1.14
52wk. High: $12.79
52wk. Low: $5.32
Ytd. Change 4.59%
50 Day Moving Average: $7.14
200 Day Moving Average: $8.61
Shares Outstanding: 223841560
Valuation
Market Cap: 141.0B
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A